Curcuminoids and metabolites thereof for treating allergic nasal conditions

A pharmaceutical composition for treating allergic conditions comprising:

• a carrier comprising a liquid medium;
• a nanoemulsified curcumin component having a mean particle size of between 5 nm and 30 nm within said liquid medium, said curcumin component being selected from the group consisting of a natural curcuminoid, a synthetic curcuminoid, a metabolite of a natural or synthetic curcuminoid, and a mixture thereof;
• and
• a pharmaceutically acceptable excipient,
• said excipient being effective in increasing the bioavailability of the curcumin component.